Quality of Life in Patients with Diabetes Mellitus Type 2 with Metabolic Neuropathy against Pathogenic Therapy

Abstract

Quality of Life in Patients with Diabetes Mellitus Type 2 with Metabolic Neuropathy against Pathogenic Therapy

Authors and Affiliations

M. V. Vlasenko

Keywords

Related Articles

Combined Pathogenetic Therapy of Diabetic Distal Neuropathy

The data on the efficacy and safety of combined pathogenetic therapy in the treatment of distal neuropathy in diabetic patients are presented. There has been demonstrated a positive clinical effect in the combined use of...

Modern Approaches to Medico-Social Examination and Rehabilitation of Disabled Patients due to Diabetes Mellitus

The results of the analysis on the primary disability due to diabetes are given. Based on the obtained data we developed criteria for determining the severity of diabetes mellitus, gave recommendations on the definition...

Features of Menstrual Disorders in Obese Women and Ways for Their Correction Using Orlistat

The research deals with the problem of reproductive health in women with obesity. In obese women, oligomenorrhea (in 62.2 % of examines patients) prevails in the structure of menstrual disorders. On the background of obe...

Insuman in Disposable Pen SoloStar: New Opportunities of insulin therapy in patients with diabetes mellitus

The article shows the importance of glycemic control in patients with diabetes and the role of insulin in maintaining blood glucose at the right level. The characteristic of modern insulins is given, an emphasis was made...

Treatment of solid nodules of the thyroid gland using laser-induced thermotherapy

Background. Indications and contraindications, methods and technologies of implementation, increased efficiency and improved long-term results are the unresolved issues when using laser-induced interstitial thermotherapy...

Download PDF file
  • EP ID EP232740
  • DOI -
  • Views 65
  • Downloads 0

How To Cite

M. V. Vlasenko (2013). Quality of Life in Patients with Diabetes Mellitus Type 2 with Metabolic Neuropathy against Pathogenic Therapy. Міжнародний ендокринологічний журнал, 1(49), 51-55. https://www.europub.co.uk/articles/-A-232740